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Abstract
There is little doubt that vitamin D deficiency across all age groups in Europe is a problem. Low vitamin D
status arises due to limited, if any, dermal synthesis during the winter months at latitudes above 408N, putting
increased importance on dietary supply of the vitamin. However, dietary intakes by most populations are low
due to the limited supply of vitamin D-rich foods in the food chain. Thus strategies that effectively address
this public health issue are urgently required. It has been emphasized and re-emphasized that there are only a
limited number of public health strategies available to correct low dietary vitamin D intake: (1) improving
intake of naturally occurring vitamin D-rich foods, (2) vitamin D fortification (mandatory or voluntarily) of
food, and (3) vitamin D supplementation. Recent evidence suggests that the levels of vitamin D added to food
would need to be high so as to ensure dietary requirements are met and health outcomes optimized. In
addition, knowledge of the most effective forms of vitamin D to use in some of these preventative approaches
is important. There is still uncertainty in relation to the relative efficacy of vitamin D2 versus D3, the two
main food derived forms and those used in vitamin D supplements. The major metabolite of vitamin D with
biological activity is 1,25(OH)2D; however, this is usually used for pharmacological purposes and is not
typically used in normal, healthy people. The other major metabolite, 25(OH)D, which has also been used for
pharmacological purposes is present in certain foods such as meat and meat products (particularly offal) as
well as eggs. This metabolite may have the potential to boost vitamin D status up to five times more effectively
that native vitamin D3 in foods. However, the exact bioactivity of this compound needs to be established.
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W
ithout doubt, vitamin D is the nutrient that has
captured the minds and imaginations of the
scientific community, authoritative agencies,
regulatory bodies, industry, and the public alike in the
first decade of the new millennium. It is notable that in
the US, the Food and Nutrition Board of the Institute of
Medicine (IOM) have very recently released new Dietary
Reference Intake (DRI) values for vitamin D (and
calcium). The European Food Safety Agency (EFSA)
will soon undertake a review of the Population Reference
Intake (PRI) values for vitamin D and other micronu-
trients in Europe. Several EU member states are also
re-evaluating their local or regional dietary recommenda-
tions for vitamin D.
These activities are not surprising in light of the
increasing evidence base during the last decade that
potentially links vitamin D to non-skeletal disease (such
as cardiovascular disease, diabetes, certain types of cancer,
infectious disease, or other autoimmune and inflamma-
tory disease that add greatly to the global burden of
disease and total chronic disease deaths) as well as to its
more accepted role in metabolic bone disease (rickets,
osteomalacia, osteoporosis) risk. An intense research
effort has resulted in this increased evidence-base as and
has facilitated agencies begin the process of re-evaluation
of dietary vitamin D recommendations. However, despite
new recommendations, vitamin D deficiency will remain a
major public health issue in Europe (and indeed else-
where), with huge potential cost implications to its health
care system and its societies unless effective dietary
strategies for prevention of vitamin D deficiency are put
in place. The present paper will overview vitamin D
deficiency, its prevalence, causes, and health effects, as
well as potential dietary strategies for its prevention. In
particular it will highlight some existing knowledge gaps
in relation to efficacy of different forms of vitamin D that
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effective preventative dietary strategies.
Vitamin D deficiency: a major concern for Europe
and the health of its populations
There is little doubt that vitamin D deficiency across all
agegroupsinEuropeisaproblem,themagnitudeofwhich
ranges from significant to pandemic depending on which
biochemical definition one uses; that is, what level of
serum 25-hydroxyvitamin D [25(OH)D; the nutritional
status measure for vitamin D] is used as the cutoff to
define deficiency. For example, it is universally accepted
thatserum25(OH)Dlevelsshouldbemaintainedabovean
absoluteminimumof25 nmol/Latalltimesforprevention
of osteomalacia in adults and vitamin D-dependent
rickets in children (1). Currently in the UK, about 21%
of adolescents (2), 25% of adults (3), and 35% of older
adults in residential care (4) are clinically vitamin D
deficient during wintertime with serum 25(OH)D levels
below 25 nmol/L. These UK prevalence data are mirrored
in other European countries. For example, Andersen et al.
(5) in their study of adolescent girls and elderly women in
four Northern European countries showed that 37% of
girls and 17% of women had wintertime serum 25(OH)D
below 25 nmol/L. The problem of low vitamin D status
spreads from Eastern to Western and from Northern to
Southern Europe (5 7).
Less severe vitamin D deficiency [represented by a
serum 25(OH)D value B50 nmol/L, although values
between 30 and 110 nmol/L have been suggested (8 10)]
causes secondary hyperparathyroidism and increases bone
turnover and bone loss (11, 12). In addition to its well-
accepted role in these metabolic bone diseases, a large
epidemiological, biologically plausible evidence base has
increased exponentially during the last decade linking low
vitamin D status [serum 25(OH)D B50 nmol/L] with
development of non-skeletal diseases (including the
cardiometabolic syndrome, diabetes, selected cancers,
respiratory infections, autoimmune and inflammatory
diseases, and cognitive decline) (13 15), which collectively
make a huge contribution to the global burden of disease
and total chronic disease deaths. However, it is worth
noting that the evidence basis for some of these outcomes
awaits data from randomized clinical trials (RCTs)
to prove cause and effect. Currently in the UK, about
40 55% adolescents (2), 70 75% of 19 64-year-old adults
(3), and up to 90% of elderly (4) are vitamin D deficient
during wintertime using a serum 25(OH)D cutoff of
50 nmol/L. These UK prevalence data are mirrored in
other European countries (5 7). For example, Andersen
et al. (5) in their study of adolescent girls and elderly
women in four Northern European countries showed that
92% of girls and 67% of women had wintertime serum
25(OH)D below 50 nmol/L. Of note this biochemical
cutoff for vitamin D deficiency was accepted recently by
the Standing Committee of European Doctors (16). Some
researchers have suggested that serum 25(OH)D levels
need to be in excess of 80 120 nmol/L to optimize health
(13, 14). Most European subjects will have serum
25(OH)D levels below this cutoff in winter and a very
high proportion will not reach it even in summer (3, 5 7).
Why does vitamin D deficiency occur so commonly
in Europe?
In humans, vitamin D is obtained primarily through
cutaneous biosynthesis in the presence of ultraviolet blue
(UVB) sunlight in summer. During wintertime in latitudes
greater than 358N, the angle of the sun is too oblique for
UVB rays to pass through ozone, so little or no vitamin D
is dermally synthesized. The duration of this period
during which vitamin D can not be synthesized increases
with latitude so, for example, human skin exposed to
sunlight on cloudless days in Boston (42.28N) from
November through February produced no previtamin
D3. In Edmonton (528N) this ineffective winter period
extended from October through March (17). There are
also many reasons why summertime sun exposure may be
inadequate. Improved adherence to public health cam-
paigns to promote sun safety and awareness of the links
between excessive sun exposure and skin cancer, as well as
premature wrinkles, has led to the widespread use of
sunscreen and inclusion of sun protection factor (SPF)
ingredients in cosmetic products. Correct application of
sunscreen with an SPF of 15 reduces cutaneous skin
production of previtamin D3 by 93% (18). Dermal
synthesis of vitamin D is a much less efficient process in
non-Caucasians than in Caucasians and in older than in
younger adults. Discreet clothing habits limit sun expo-
sure particularly in veiledwomen and long working hours
spent indoors mean that most adults rely on vacation
to spend time outdoors during the day.
In the absence of sufficient UVB for dermal synthesis,
vitamin D becomes an essential nutrient; however, food
sources of vitamin D are few and the typical average
vitamin D intakes in populations within the EU are
generally around 2 5 mg/d (19). There is a significant gap
between typical intakes in European populations and the
current dietary targets (10 and 15 mg/d for 1 70 years;
10 and 20 mg/d for  70 years; US Estimated Average
Requirement and Recommended Dietary Allowance
values, respectively (8)). Even these new DRI values are
not as high as those proposed by some researchers (22).
For example, data from nationally representative surveys
shows that 74% of adults in the UK and Ireland are not
reaching an intake of 5 mg/d and 90% of older men and
women in Ireland are not reaching 10 mg/d (20, 21). The
European dietary recommendation (PRI) for vitamin D
for adults also reveals considerable uncertainty about the
available evidence on which to base a recommended
intake, as it ranges from 0 to 10 mg/d to account not
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varying latitudes that EU citizens live in (35 708N),
assuming a higher dietary requirement in more northerly
latitudes but not having data to base a requirement on
(23). Two recent controlled, randomized, double-blind
vitamin D3 intervention trials, the first in 245 adults aged
20 40 years (24) and the second in 225 community-
dwelling adults over 64 years (25), showed that the
estimated dietary requirements (covering needs of 97.5%
of population) for vitamin D in men andwomen (aged 20 
40 years and 64  years) to maintain serum 25(OH)D
above 25 nmol/L during winter were 8.6 and 8.7 mg/d,
respectively. Using the 50 nmol/L cutoff, the requirements
raised to 24.7 and 28.0 mg/d for 20 40 and 64-year-olds,
respectively. Estimates of the dietary vitamin D require-
ment to reach a serum 25(OH)D threshold of 80 nmol/L
in adults and elderly range from 41 to 114 mg/d (24 26).
Of particular concern, these new target values (even the
lowest ones) are considerably beyond current intakes in
adolescent (2, 27) and adult populations (in some cases
even the high consumers (reflected by those in the
95 percentile of intake) have vitamin D intakes below
9 mg/d (19). As an example, 84 97% of adolescents (2)
and 93% of adults (20) in the UK National Diet and
Nutrition Survey do not reach an intake of 5 and 9 mg/d,
respectively.
Addressing the low intake and associated
vitamin D deficiency
As mentioned already, in humans, vitamin D is obtained
primarily through cutaneous biosynthesis in the presence
of UVB sunlight in summer. While stores established
during summer sun exposure can help reduce the
requirement for dietary vitamin D in wintertime, it does
not negate this (24, 25). In addition, it is worth noting
that population levels of unprotected summer sun
exposure may be rapidly declining, as a consequence of
public education campaigns in relation to skin cancer
(28). Thus, dietary supply of vitamin D is taking on
increasing importance not only in winter months but
potentially also in summer; however, dietary supply is low
for most European populations. It has been emphasized
and re-emphasized that there are only a limited number
of public health strategies available to correct low dietary
vitamin D intake:
1. Improving intake of naturally occurring vitamin
D-rich foods. However, this is the least likely strategy
to counteract low dietary vitamin D intake due to
the fact that there are very few food sources that
are rich in vitamin D. Furthermore, most of these
are not frequently consumed by many in the
population (21).
2. Vitamin D fortification (mandatory or voluntarily) of
food. This has been viewed by some as a feasible and
effective measure once applied in an evidence-based
approach. In response to concerns about wides-
pread vitamin D deficiency, many countries have
implemented either mandatory or discretionary food
fortification. Fortification of foods with vitamin D
in the US and Canada has an important impact on
the mean daily intake of vitamin D by the average
adult. Fortified foods constitute the largest contri-
butor (65 87%; and fortified milk alone contributes
40 64%) to dietary vitamin D intake in the US
population (29). However, Calvo and Whiting (30)
suggest that the current level of fortification in the
US and Canada is not effective in reaching the
required levels of vitamin D intake (i.e. existing
dietary targets, which are much lower than those
shown by the recent RCTs described above). This
may relate to the level of fortification, types and
choice of food vehicles, and the issue of mandatory
or optional/voluntary fortification. O’Donnell et al.
(31), in their recent systematic review of the efficacy
of food fortification on serum 25(OH)D concentra-
tions, showed that of the nine RCTs (n 889
subjects, all community-dwelling participants; most
used dairy products as the source of vitamin D
fortification) that were included, eight consistently
showed a significant beneficial effect of food for-
tification on 25(OH)D concentrations. The authors
concluded that their review highlights the need for
stronger data on food fortification. Flynn et al. (19)
have recently shown that the 95th percentile of
intake of vitamin D from voluntary fortified foods
in Europe is low. Thus, from a European perspective
we need to model European food and vitamin D
intake data to ascertain which food vehicles and
what level of vitamin D addition will ensure an
effective but safe rise in serum vitamin D status in
European populations. So there is a need to invest
in such research.
3. Vitamin D supplementation. Supplementation with
vitamin D has been shown to significantly im-
prove vitamin D intake across a variety of age, race,
ethnic, and gender groups (30) as well as improving
vitamin D status per se (efficacy of which dependent
on dose) (32). However, evidence seems to suggest
that the population intake of vitamin D from
supplements is quite low (19). For example, although
supplements contribute  12 and 7% to vitamin D
intakesinIrishwomenandmen,respectively(33)and
almost a quarter of vitamin D intakes in women and
12% in men in the UK (20), overall intakes are low so
these contributions while proportionally high are
quantitatively low. This is a function mainly of the
relativelylowvitaminDcontentofmostsupplements
insomecountriesrelativetorequirementasdiscussed
above. Some are of the view that while not highly
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tation may be appropriate in high risk groups such as
the elderly (16, 34, 35).
Forms of vitamin D and relative efficacy in
improving status
While recent evidence suggests that the levels of vitamin
D added to food and/or supplements would need to be
high so as to ensure dietary requirements are met and
health outcomes optimized, knowledge of which are the
most effective forms of vitamin D to use in some of these
preventative approaches is also important.
Vitamin D2 versus D3
While vitamin D2 and D3 [the two main food derived
forms (although vitamin D2 only occurs in wild mush-
rooms) and those used in vitamin D supplements] both
unquestionably elevate serum 25(OH)D as evidenced in a
recent systematic review of biomarkers of vitamin D
status (32), there is still uncertainty in relation to the
relative efficacy of these two forms of vitamin D. For
several decades, pharmacopoeias have officially regarded
these two forms as equivalent and interchangeable, yet
the evidence base for this was old and largely based on
studies of rickets prevention in infants in the 1930s.
There have been a number of human studies that
directly compared the two forms of vitamin D in terms of
their potential for raising serum 25(OH)D in adults.
Trang et al. (36) compared the ability of an equal molar
dose of vitamin D2 or D3 [:4,000 IU (100 mg)/d] to
elevate serum total 25(OH)D (via radioimmunoassay)
over 2 weeks between February and early May when
vitamin D concentrations and solar exposure are minimal
in 72 healthy men and women (mean age, 38 years). Both
vitamin D2 and vitamin D3 increased serum total
25(OH)D concentrations, but the increase in total
25(OH)D was found to be 70% greater (1.7 times) with
vitamin D3 than the increase obtained with vitamin D2.
Armas et al. (37) compared the time course of serum total
25(OH)D (via radioimmunoassays) over a period of 28
days after a single dose of either vitamin D2 or vitamin
D3 [50,000 IU (1250 mg)] in 20 healthy males (mean age,
33.0 years) in summertime (July) [necessitating the
researchers having to account and adjust for increases
in serum 25(OH)D due to sun exposure]. Both forms of
vitamin D produced similar rises in serum total 25(OH)D
concentration over the first 3 d, but serum 25(OH)D
continued to rise in the vitamin D3-treated subjects
(peaking by day 14 and remaining above baseline until
at least day 28), whereas in the vitamin D2-treated
subjects, serum 25(OH)D concentrations fell rapidly,
reaching baseline values by day 14. Interestingly,
25(OH)D concentrations then continued to decline in
this group and fell below baseline values by day 28. A
comparison of the areas under the curve (concentration
versus time) showed a  threefold greater potency
with vitamin D3. A surprising finding was a decline
in 25(OH)D3 concentrations (via HPLC assay) in
the vitamin D2-treated subjects, whereas concentrations
rose in the control group (due to sun exposure)
(37). Glendenning et al. (38) studied whether 1,000 IU
(25 mg)/d of vitamin D2 and D3 are equipotent therapies
in vitamin D-insufficient [serum 25(OH)D B50 nmol/L]
hip fracture patients (n 95). Vitamin D3 supple-
mentation resulted in a 31% greater increase in total
HPLC-measured 25(OH)D and 52% greater rise in
radioimmunoassay-measured total 25(OH)D than sup-
plementation with an equivalent dose of vitamin D2 after
3 months. The authors also reported a lack of difference
in PTH lowering between the two forms of vitamin D
treatments and raised questions about the biological
importance of the greater potency with vitamin D3.
Houghton and Vieth (39), in their review of the
available data and evidence, provide a very succinct
overview of several biologically plausible mechanisms
that could contribute to the greater capacity of vitamin
D3 over D2 to maintain higher 25(OH)D concentrations
over time, including:
1. Serum 25(OH)D2 has a lower affinity for vitamin D-
binding protein (DBP) and results in a shorter
circulating half-life than that of 25(OH)D3.
2. A higher affinity of hepatic 25-hydroxylase for
vitamin D3 than for vitamin D2.
3. Minor differences in the chemistry of side chains
between the two forms of vitamin D result in dif-
ferences in the site of hydroxylation and leads to the
production of unique biologically active metabolites:
. After 25-hydroxylation, 25(OH)D, and 1,25
(OH)2D undergo additional 24-hydroxylation
in the kidney to form 24,25(OH)2D and 1,24,
25(OH)3D, respectively.
. The formation of 1,24,25(OH)3D2 leads to
deactivation of the vitamin D2 molecule,
whereas the analogous vitamin D3 metabolite,
1,24,25(OH)3D3, must undergo additional side-
chain oxidation to be biologically deactivated.
1,24,25(OH)3D3 has the ability to bind to the
vitamin D receptor [VDR; :40% more than
1,25(OH)2D3] and, thus, is able to potentially
generate significant biological activity.
. While 24-hydroxylation of the side chain could
occur only after 25-hydroxylation, at least for
vitamin D3, it does not appear to be a prerequi-
site for vitamin D2. 1,24(OH)2D2, formed in the
kidney from 24(OH)D2, has less affinity for
VDR than do 1,25(OH)2D3 and 1,24(OH)2D3.
Binding to VDR represents a molecular event
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are taken together, the most plausible explanations for the
greater bioefficacy of vitamin D3 are conceivably due to
the higher affinities of vitamin D3 and its metabolites
than vitamin D2 for hepatic 25-hydroxylase, DBP, and
VDR and because vitamin D3 is not directly metabolized
to 24(OH)D as is vitamin D2. Interested readers are
referred to this review for a more comprehensive coverage
of the potential mechanisms (39).
While the findings from the above studies and possible
underlying mechanisms might suggest so, the case for
greater bioefficacy of vitamin D3 over vitamin D2 is less
than clear. Rapuri et al. (40) reported that in a study of
elderlywomen(meanage,72years)whoself-reportedtheir
use of vitamin D2 and D3 supplements, the mean serum
total 25(OH)D levels (via competitive protein binding
assay) were higher in women onvitamin D2 (33.692.1 ng/
mL) and vitamin D3 (29.791.8 ng/mL) supplements
(mean dose, 401 and 465 IU/d, respectively) compared to
unsupplemented women (27.390.7 ng/mL) during win-
tertime. In fact, the difference was only significant for
those on vitamin D2. Holick et al. (41) showed that
elevations in serum total 25(OH)D concentrations (via
liquid chromatography tandem mass spectroscopy) were
identical between healthy adult men and women (n 68;
mean age, 38.6 years) given 1,000 IU (25 mg)/d vitamin D2
or vitamin D3 or a combination of 500 IU/d of vitamin D2
plus 500 IU/d of vitamin D3 (1,000 IU/d in total) in
capsule form at the end of the winter for 3 months.
Furthermore, the 25(OH)D3 levels did not change in the
group that received 1,000 IU vitamin D2 daily. Similarly,
infants (mean age, 10 months) who received 2,000 IU
(50 mg) daily or 50,000 IU (2,000 mg) vitamin D2 weekly
for6weeks(throughouttheyear)experiencedanelevation
in serum total 25(OH)D concentrations (via a chemilumi-
nescent assay) equivalent to concentrations observed in
children who received 2,000 IU vitamin D3 daily (42).
Biancuzzo et al. (43) very recently showed in a study
of healthy adult men and women (n 105; mean age,
40.3 years) in late winter that, using analysis of the area
under the curve, there was no significant difference in
serum total 25(OH)D (via liquid chromatography tandem
mass spectroscopy) between subjects who consumed
vitamin D3-fortified orange juice andvitamin D3 capsules.





orange juice or in a capsule. Thus, these latest findings
appeartosuggestthatnotonlyarevitaminD2andvitamin
D3 equally bioavailable, they are so from a fortified food
source or a capsule.
It is clear that the data are ambiguous and may stem
from the fact that the various studies that have compared
the two forms of vitamin D have had differences in design
(season in which study conducted, age profile of sub-
jects), dose/mode of administration of vitamin D, pre-
paration of vitamin D, as well as method of analysis of
serum 25(OH)D, all of which may have contributed to the
mixed findings and limit a firm conclusion being drawn
at this time.
Vitamin D metabolites
The major metabolite of vitamin D with biological
activity is 1,25(OH)2D; however, this is usually used for
pharmacological purposes and is not typically used in
normal healthy people. The presence of minor amounts
of this metabolite in some foods of animal origin (as is
the case with 25(OH)D; see below) and its contribution to
biological vitamin D activity has not been investigated.
It has been suggested that the other major metabolite,
25(OH)D, which has also been used for pharmacological
purposes, may contribute to vitamin D nutriture. This
metabolite is present in certain foods of animal origin.
Meat, eggs, and to a lesser extent fish have been shown to
possess 25(OH)D (44 47). There has been some limited
investigation of offal (and in particular liver and kidney),
which shows that they contain higher amounts of the
metabolite than cuts of meat (which is not surprising as
these tissues are where vitamin D is metabolized in vivo)
(48, 49). For example, pork liver appears to have
equivalent amounts of vitamin D3 and 25(OH)D
(0.4 mg per 100 g), while beef liver has more 25(OH)D
than vitamin D3 [B0.05 mg and 0.3 mg 25(OH)D per 100
g, respectively] (45). Chicken also appears to have
equivalent amounts of vitamin D3 and 25(OH)D
(0.3 mg and 0.25 mg per 100 g, respectively) (45), while
eggs yolk have 3 mg vitamin D3 and 1 mg 25(OH)D per
100 g, respectively (44).
Meat and meat products as well as egg and egg dishes
can make sizeable contributions to the mean daily intake
of vitamin D for some populations (20, 21). However,
some of this contribution stems from the fact that the UK
(and others such as Danish and Swiss) food composition
tables suggests that 25(OH)D may possess up to five times
the activity of native vitamin D3 in food (50 52). Thus,
in theory, each mg of 25(OH)D consumed in the diet could
boost vitamin D status up to five times more effectively
compared to each mg of native vitamin D3 in food. Thus,
food-based 25(OH)D may be a very valuable strategy for
bridging the gap between current intakes and new dietary
targets for vitamin D (9 10 or 15 mg/d; 8, 24,25) (24, 25).
Forexample, if habitual daily intakes of vitamin D in most
European populations are in the region of  4 mg (19),
then an additional 5 mg/d of vitamin D would need to be
achieved via diet to reach a target of 9 mg/d or potentially
onlyanadditional 1 mg/d 25(OH)D from food. Thiswould
only be the case if the relative potency of 25(OH)D to the
native vitamin D is 5, but as Ovesen et al. (48) point out
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should be used for 25(OH)D to calculate vitamin D
activity. Depending on the testing system used, the factor
varies from 1.5 to 5 (48). Moreover, Jakobsen et al. (53)
recently showed in a 12-week pig feeding trial that in
relation to benefits for human nutrition, 25(OH)D in pig
feed should be regarded as lower thanvitamin D3, as meat
and liver produced by feeding the pigs exclusively
25(OH)D had a significantly low content of vitamin D3.
Priority needs to be given to data from human studies that
have experimentally examined this relative potency. Using
data from a 1-year intervention study by Rossini et al. (54)
in osteopenic/osteoporotic women with hypovitaminosis
D, it can be estimated that vitamin D3 and 25(OH)D may
have about equal potency (with the latter being only
 1.4-fold more potent than vitamin D3). In contrast, in a
preliminary publication, Jetter et al. (55) recently showed
that healthy postmenopausal women (aged 50 75 years)
who were supplemented daily with 20 mg/d of 25(OH)D
had more than a twofold greater increase in serum
25(OH)D after 16 weeks compared to those who were
supplemented with 20 mg/d of vitamin D3 over the same
time frame. Clearly, further research is needed to better
define the relative potencyof 25(OH)D present in foods so
that food compositional tables can better reflect the true
vitamin D nutritive value of meats, fish, and eggs, but also
in terms of whether this metabolite is something that
could be used for dietary supplementation/fortification
purposes.
Conclusion
Without question there is a need to address the shortfall
in current intakes of vitamin D in European and other
populations relative to existing and potentially new and
higher dietary recommendations. Fortification of foods
with vitamin D as well as vitamin D supplementation in
specific at-risk groups would appear to be likely strategies
that may address low vitamin D status at a population
level. Further research is needed to clarify whether
differences in potency of vitamin D2 and D3 really do
exist and to ascertain the exact relative potency of
25(OH)D to vitamin D3. Such research will inform the
dietary strategies aimed at prevention of vitamin D
deficiency.
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